Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Felbamate

I E Leppik1

  • 1MINCEP Epilepsy Care, Minneapolis, MN 55416-1222, USA.

Epilepsia
|January 1, 1995
PubMed
Summary

Felbamate (FBM) is a valuable antiepileptic drug for intractable epilepsy, but side effects like nausea and insomnia can occur. Careful dosing and co-medication management can mitigate these, but aplastic anemia risk necessitates physician supervision.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effect of topiramate plasma concentration on linguistic behavior, verbal recall and working memory.

Epilepsy & behavior : E&B·2012
Same author

Double-masked, placebo-controlled study of intravenous levetiracetam for the treatment of status epilepticus and acute repetitive seizures in dogs.

Journal of veterinary internal medicine·2012
Same author

Steady-state carbamazepine pharmacokinetics following oral and stable-labeled intravenous administration in epilepsy patients: effects of race and sex.

Clinical pharmacology and therapeutics·2012
Same author

Zonisamide discontinuation due to psychiatric and cognitive adverse events: a case-control study.

Neurology·2010
Same author

Phenytoin half-life and clearance during maintenance therapy in adults and elderly patients with epilepsy.

Neurology·2008
Same author

Intramuscular, intravenous and oral levetiracetam in dogs: safety and pharmacokinetics.

Journal of veterinary pharmacology and therapeutics·2008

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Felbamate (FBM) has emerged as a potentially valuable antiepileptic drug (AED) for treating intractable epilepsy.
  • Clinical experience highlights both the efficacy and the side effect profile of FBM.

Purpose of the Study:

  • To evaluate the clinical utility of felbamate in epilepsy treatment.
  • To identify common side effects and strategies for managing them.
  • To assess the risk-benefit profile of FBM, including serious adverse events.

Main Methods:

  • Review of clinical experience with felbamate over the first year of its use.
  • Analysis of patient-reported side effects and their management.
  • Consideration of recent observations regarding serious adverse events like aplastic anemia.

Main Results:

  • Felbamate demonstrates value in treating intractable epilepsy.
  • Nausea and insomnia are common troublesome side effects.
  • Slower dose escalation and reduced co-medication may decrease side effect incidence.
  • Aplastic anemia is a serious risk associated with FBM.
  • Many patients benefit significantly and accept the current risk profile.

Conclusions:

  • Felbamate remains a viable option for intractable epilepsy, particularly when managed carefully.
  • Physician familiarity with FBM and its risks is crucial, especially given the potential for aplastic anemia.
  • Further long-term data is needed to fully establish the definitive role of FBM in epilepsy management.

Related Experiment Videos